ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

Brain tumor foundations form collaboration.

July 15, 2005

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

Oncology Unit – How To Plan, Start It

February 10, 1978

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

IOM Report Links Agent Orange, CLL

January 24, 2003

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993